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Introduction: Although thymic epithelial tumors (TETs) commonly 
infiltrate mediastinal structures, cardiac involvement is uncom-
mon and has not been systematically studied. The purpose of this 
study was to describe our single-institution experience of the clini-
cal presentation, treatment, and follow-up of cardiac involvement in 
patients with TETs.
Methods: A single-institution retrospective review of cardiac 
involvement among patients with TETs from 2008 to 2012.
Results: The frequency of cardiac involvement was 4%. All five 
patients with confirmed cardiac disease had left heart involve-
ment. Only one patient was symptomatic. Myocardial invasion was 
the most common mode of involvement followed by transvenous 
spread. Surgical resection of the involved area was attempted in 
three patients: in one, surgery was aborted because of extensive 
myocardial involvement; in the other two patients, resection was 
incomplete. Surgery averted a potentially catastrophic hemody-
namic complication in one patient. However, cardiac tumor recurred 
in both patients who underwent incomplete resection. One patient 
underwent radiation therapy resulting in complete regression of an 
aortic root mass.
Conclusions: This study represents the most comprehensive review 
of cardiac involvement in patients with TETs. In contrast to previ-
ous single-case reports, we found a preponderance of asymptom-
atic presentation, left heart involvement, and myocardial invasion. 
Dynamic cardiovascular magnetic resonance imaging should 
be considered in cases when cardiac involvement is suspected. 
Although immediate surgical resection is indicated for impend-
ing hemodynamic compromise, long-term palliation with surgery 
for myocardial involvement seems poor, especially when complete 
resection cannot be performed. Radiation therapy should be consid-
ered in selected patients.
Key Words:  Thymic epithelial tumors, Cardiac tumors, Cardiovascular 
magnetic resonance imaging.
(J Thorac Oncol. 2013;8: 246–249)
Thymic epithelial tumors (TETs) are the most common anterior mediastinal tumors in adults.1 TETs tend to spread 
along the serosal surfaces, that is, along the pleura and peri-
cardium. Although it commonly infiltrates mediastinal struc-
tures, cardiac extension is often limited to the pericardium, and 
intracardiac extension is rare.2 There are several single-case 
reports of intracardiac extension of TETs, but these reports 
lack details of treatment, follow-up, outcomes and also details 
of cardiac involvement because of use of computed tomogra-
phy (CT) or echocardiogram as primary imaging modalities. 
To our knowledge, there are no systematic reports of clinical 
presentation, patterns of involvement, treatment, and outcome 
of cardiac involvement in TETs.
MATERIALS AND METHODS
A retrospective review was performed of patients with 
TETs who were evaluated in the Thoracic Oncology Clinic, 
National Cancer Institute (Bethesda, MD), to study the clini-
cal presentation, patterns of cardiac involvement, treatment, 
and outcome. All patients had histologically confirmed thy-
moma or thymic carcinoma. Dynamic cardiovascular mag-
netic resonance imaging (cardiac MRI) was performed (1.5 
Tesla, gadolinium enhancement) when cardiac involvement 
was suspected on computed tomography/echocardiogram or 
before surgery after neoadjuvant chemotherapy. Demographic 
information, treatment history, details of cardiac involvement, 
tumor characteristics, treatment, and follow-up were obtained 
from medical records. All patients were enrolled on investi-
gational protocols and signed consents were approved by the 
institutional review board.
RESULTS AND DISCUSSION
One hundred twenty-two patients with TETs were 
evaluated between January 2008 and June 2012. There was 
a comparable number of patients with thymoma 59 (48%) 
and thymic carcinoma 63 (52%). Nearly all patients (98%) 
presented with advanced stages (Masaoka stage III and IV) of 
disease. Cardiac involvement was diagnosed in five (men 3; 
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women 2; age range, 31–60 years). Demographic information, 
details of cardiac involvement, treatment, outcome, and 
follow-up of patients are summarized in Table 1. Only five 
patients (4%) had confirmed cardiac involvement (Fig. 1). All 
five patients had left heart involvement, a finding that has been 
rarely described in TETs. Left ventricle (LV) was involved in 
three patients (cases 1, 4, and 5) whereas left atrium (LA) was 
involved in two (cases 2, 3). We are aware of only one prior 
report of LV involvement with TETs.3
Tumor involvement of the heart can manifest in differ-
ent ways: lung or mediastinal mass with direct invasion of 
adjacent heart; central mass extending into the LA and right 
atrium (RA) via the pulmonary vein and vena cava, respec-
tively; pericardial effusion; or myocardial infiltration.4 In 
this series, one patient (case 2) had transvenous intracardiac 
extension via the pulmonary vein whereas others had myocar-
dial invasion (cases 1, 3, 4, and 5) from adjacent lung, medi-
astinal or epicardial mass. In two patients, the myocardial 
TABLE 1.  Patient Demographic Information, Details of Cardiac Involvement, Treatment, Outcome, and Follow-Up 
Pt. No 
(Age, sex)
Stage/ 
Histology at 
Diagnosisa
Time from Initial 
Diagnosis to 
Detection of Cardiac 
Involvement (yrs)
Areas of 
Cardiac 
Involvement
Mode of 
Cardiac 
Involvement
Histology 
of Cardiac 
Mass Treatment Outcomeb Follow-Upb
1 (31, M) IVA/AB 3 LV, RA, 
SVC 
IV via 
myocardium
B3/TC S (R2) Cardiac and 
extracardiac recurrence 
at 6 weeks
Continuing 
systemic therapy 
at 10 mo
2 (44, M) IVB/AB 8 LA IA via PV TC S (R2) Cardiac recurrence at 2 
weeks and extracardiac 
recurrence at 3 mo
Died at 5 mo
3 (60, F) IVA/B3 4 LA, AoR, 
RA
IA via 
myocardium
NA IMRT Shrinkage of cardiac 
and extracardiac tumors
No evidence of 
disease at 8 mo
4 (60, M) IVA/B3 7 LV Myocardium NA Observation Stable cardiac 
involvement at 2 yrs
Continues 
systemic therapy 
at 2.7 yrs
5 (40, F) IVA/B1 0.6 LV Myocardium B2 S (R2) Extracardiac PD at 2 mo Died at 7 mo
LA, left atrium; SVC, superior vena cava; RA, right atrium; PV, pulmonary vein; LV, left ventricle; AoR, aortic root; IA, intraatrial; IV, intraventricular; TC, thymic carcinoma; NA, 
not applicable; PD, progressive disease; S, surgical resection; R2, residual gross disease remains unresected; IMRT, intensity-modulated radiation therapy.
aMasaoka stage and World Health Organization histologic grade.
bOutcome and follow-up are recorded as time elapsed from surgery, radiation (patients 1,2, 3, 5) or from detection of cardiac involvement (patient 4).
FIGURE 1.  Various presentations of cardiac involvement of thymic malignancies using cardiac magnetic resonance imaging 
(top frame) and corresponding CT images (lower frame) are depicted. A, Left atrioventricular groove mass (arrows) with direct 
intraventricular extension (upper left corner) from case 1. B, Left atrial mass (arrows) is depicted extending from contiguous lung 
mass invasion via pulmonary vein (upper right corner) in case 2. C, Direct intraatrial invasion (arrows) of extracardiac mass found 
in case 3. D, Left anterior wall mass (arrows) with direct myocardial invasion as seen in case 5. E, Direct myocardial extension into 
the lateral wall of the left ventricle seen in case 4. CT images were not electrocardiogram-gated during acquisition. CT image for 
case 3, courtesy of Dr. Christopher Sibley, MD. Cardiac structures are labeled. CT, computed tomography; RA, right atrium; LA, 
left atrium; RV, right ventricle; LV, left ventricle; AoV, aortic valve; AO, aorta; PA, pulmonary artery; CT, computed tomography.
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involvement extended as intracardiac masses (cases 1 and 3). 
In previous reports, extension of tumor thrombus into RA via 
the superior vena cava (SVC), presumably because of inva-
sion of thymic vein that drains into the brachiocephalic vein, 
was the most common mode of cardiac invasion, followed 
less commonly by direct invasion from adjacent tumor.3,5,6 The 
majority of patients in previous reports came to medical atten-
tion with symptoms related to SVC obstruction, reflecting 
the greater frequency of RA/SVC involvement. In this series, 
cardiac involvement was diagnosed while patients were still 
asymptomatic, with only one exception (case 2).
Autopsy reports suggest that myocardial involvement 
with cancer overall is rare.7 Four patients (cases 1, 3, 4, and 
5) had areas of atypical gadolinium enhancement on cardiac 
MRI, suggestive of myocardial involvement. In two of them 
(cases 1 and 5), myocardial involvement was confirmed intra-
operatively wherein dense myocardial invasion precluded 
complete surgical resection. Despite LV myocardial involve-
ment, LV systolic and diastolic function was preserved in 
two of the four patients (cases 1 and 5). In one patient, an 
observed decrease in LV ejection fraction (45%; case 4) was 
likely because of concurrent coronary artery disease. In previ-
ous reports, only six cases of myocardial involvement of TETs 
have been described.3,5,8–10
In three patients (cases 1, 2, and 5), the histologic 
appearance of intracardiac tumors was different from that at 
initial diagnosis. In case 1, histologic features of the intracardiac 
mass resembled thymic carcinoma, but organotypic features 
were maintained, favoring a diagnosis of B3 thymoma (Fig. 2). 
In case 2, pathology of the intracardiac mass showed poorly 
differentiated carcinoma with extensive necrosis. In both cases, 
the initial histology was AB thymoma. In case 5, the initial 
histology was B1, whereas the intrapericardial tumor was 
B2. The histologic evolution could possibly be a reflection of 
tumor heterogeneity and the extent of sampling.11 However, the 
histologic changes, specifically in cases 1 and 2, could represent 
transformation of a preexisting thymoma to a more malignant 
phenotype and may have contributed to increased invasiveness. 
Previous reports have documented the association of increased 
tumor growth and invasiveness with the emergence of carcinoma 
from thymoma and support the existence of a continuum of 
differentiation between thymoma and thymic carcinoma.12
Although MRI is not used routinely in TETs, it provides 
improved resolution, soft-tissue contrast, and tissue character-
ization. Malignant tumors, in general, have low signal intensity 
on T1-weighted images, high signal intensity on T2-weighted 
images, and varying degrees of enhancement after contrast 
material administration. MRI is also useful in distinguishing 
thymomas from thymic carcinoma and can better delineate the 
extent of involvement to guide surgical and/or radiation therapy 
(RT) planning.13,14 Dynamic cardiac MRI should be strongly 
considered in TETs when cardiac involvement is suspected.
Complete surgical resection is the mainstay of therapy 
for thymomas and is the most important predictor of long-
term survival.2 However, in select patients incapable of being 
rendered completely disease-free, debulking may be worthwhile 
for either palliation or to avoid catastrophic complications.15 
One patient (case 2) underwent emergent surgical resection of 
intracardiac mass because of prolapse of the LA mass through 
the mitral annulus, causing functional mitral flow obstruction 
(Video 1, Supplemental Digital Content 1, http://links.lww.
com/JTO/A379). Although the intracardiac mass was excised, 
extracardiac component of the tumor could not be completely 
resected because of dense adhesions to myocardium from prior 
surgeries. Complete surgical resection could not be achieved in 
a second patient (case 1) because of intimate tumor involvement 
at the level of posterior atrioventricular groove and the nearby 
epicardial cardiac vessels, and thus residual infiltrative tumor 
remained. Surgical resection was attempted in a third patient (case 
5), but had to be aborted because of extensive intrapericardial 
sac involvement and direct tumor extension through the 
pericardium into myocardium in several areas. In both cases 
1 and 2, rapid tumor recurrence was noted in the areas where 
tumor was incompletely excised, with recurrences detected at 
6 and 2 weeks after cardiac surgery, respectively. Patient 1 had 
rapid progression of disease despite successive treatments with 
systemic therapies and at 10 months after surgery was receiving 
a third agent. Patient 2 had a complicated postoperative course 
with recurrent infections, cardiac arrhythmias, and respiratory 
failure, resulting in death 5 months after surgery. Patient 3 
was found to have rapidly progressive extracardiac disease 2 
months after the attempted surgical resection and died 7 months 
later after failing to respond to two systemic therapies. In 
patients with myocardial involvement, resection may often be 
incomplete. Although immediate surgical resection is indicated 
if hemodynamic compromise is imminent from obstructed 
cardiac outflow by an intracardiac lesion (case 2), long-term 
palliation with surgery for myocardial involvement seems poor. 
Hence, surgery should be considered for cardiac involvement 
of TETs only if complete resection of tumor can be achieved. 
Alternatively, induction chemotherapy may be an option in 
patients with no impending compromise and limited cardiac 
FIGURE 2. A, Histologic appearance of the anterior 
mediastinal tumor of patient 1 at diagnosis showing 
features of AB thymoma. B, Cardiac tumor of the 
same patient approximately 3 years after diagnosis, 
shows histologic features resembling thymic carci-
noma with areas of necrosis (bold arrow) and mitotic 
figures (thin arrow). Because organotypic features 
were maintained, a diagnosis of B3 thymoma was 
favored (hematoxylin-eosin, original × 40).
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involvement. No intervention was considered for a patient (case 
4), whose cardiac involvement remained stable for over 2 years. 
He continues to receive systemic therapy for slow progression 
of extracardiac disease. Among the previously reported cases 
of myocardial involvement, one patient underwent incomplete 
surgical resection and died 1 month later.9 Two patients who 
underwent complete resection of atrial myocardial involvement 
had no evidence of recurrence 6 months and 29 months after 
surgery.8,10 In the other three cases, neither treatment details nor 
outcome were reported.3,5
RT may not be feasible in many cases because of prior 
radiation to the field, prior doxorubicin exposure, or risk of 
direct cardiac toxicity. The latter is dependent on the location 
and proportion of the myocardium that will be included in 
the treatment portals, as well as the dose of radiation to be 
administered. Patient 3 was not referred for surgery because 
of involvement of an area that was thought to be amenable to 
RT. She safely received a definitive dose of 63 Gy directed 
to the aortic root with sufficient sparing of heart, resulting in 
complete regression of the cardiac mass on follow-up. She 
remains asymptomatic with no evidence of disease 8 months 
after RT. In patients with incomplete excision, given the rapid 
rate of recurrence, postoperative RT may be considered.
In addition to being the largest series of patients with a 
systematic assessment of cardiac involvement, the strengths 
of this study include detailed visualization using cardiac MRI, 
pathologic confirmation (in operative cases), and availability 
of long-term follow-up. Besides the inherent biases associated 
with a retrospective series, overdiagnosis of asymptomatic 
cardiac involvement may have resulted from frequent use of 
imaging studies in the setting of clinical protocols.
CONCLUSION
We identified five cases of cardiac involvement from 
TETs in a retrospective review. The patients exhibited sev-
eral uncommon features including left-sided and infiltrative 
myocardial involvement. Patients with TETs who present 
with paracardiac masses should be closely monitored radio-
logically for cardiac involvement because development of 
symptoms may occur late. MRI is an useful tool when cardiac 
involvement is suspected, to delineate the extent of involve-
ment, determine resectability, and plan RT. Early recognition 
of intracardiac involvement might facilitate complete surgical 
resection. There is no benefit for incomplete surgical resec-
tion. RT in selected inoperable cases can prevent or delay car-
diac complications.
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VIDEO 1.  Large mass protruding into the left atrium as 
it extends along a pulmonary vein from a contiguous lung 
mass as seen on cardiovascular magnetic resonance steady-
state free precession cine imaging in case 2. As depicted, the 
intraatrial portion of the mass has two heads, one of which 
is mobile and prolapses partially through the mitral annulus 
during diastole.
